3-Methyl-8-Quinolinesulphonyl Chloride CAS 74863-82-4 Argatroban Intermediate Factory 98.0%

Tsanangudzo Pfupi

Kemikari Zita: 3-Methyl-8-Quinolinesulphonyl Chloride

CAS: 74863-82-4

Kuonekwa: White Crystalline Powder

Kuchena:> 98.0% (HPLC)

Pakati peArgatroban (CAS 74863-84-6), Synthetic Thrombin Inhibitor.Antithrombotic

High Quality, Commercial Production

Inquiry: alvin@ruifuchem.com


Product Detail

Related Products

Product Tags

Tsanangudzo:

Chemical Properties:

Chemical Name 3-Methyl-8-Quinolinesulphonyl Chloride
Mashoko anoreva zvakafanana 3-Methylquinoline-8-Sulfonyl Chloride
Nhamba yeCAS 74863-82-4
Nhamba yeCAT RF-PI269
Stock Status MuStock, Kugadzirwa Kunokwira Kusvika Matani
Molecular Formula C10H8ClNO2S
Molecular Weight 241.69
Density 1.4±0.1 g/cm3
Refractive Index 1.63
Solubility Soluble muChloroform
Shipping Condition Yakatumirwa Pasi peAmbient Temperature
Brand Ruifu Chemical

Zvinotsanangurwa:

Item Zvinotsanangurwa
Chitarisiko White Crystalline Powder
Kuchena / Analysis Method >98.0% (HPLC)
Melting Point 162.0~163.0℃
Kurasika paKuomesa <0.50%
3-Methylquinoline-8-Sulfonic Acid <1.00%
Zvose Zvisina Kuchena <2.00%
Infrared Spectrum Inopindirana neChimiro
NMR Inopindirana neChimiro
Test Standard Enterprise Standard
Usage Pakati peArgatroban (CAS 74863-84-6)

Package & Kuchengeta:

Package: Bhodhoro, Aluminium foil bag, 25kg/Cardboard Drum, kana zvinoenderana nezvinodiwa nemutengi.

Storage Condition:Chengetedza mumidziyo yakavharwa panzvimbo inotonhorera uye yakaoma;Dzivirira kubva kuchiedza & mwando

Zvakanakira:

1

FAQ:

Application:

Shanghai Ruifu Chemical Co., Ltd ndiyo inotungamira mugadziri uye mutengesi we3-Methyl-8-Quinolinesulphonyl Chloride (CAS: 74863-82-4) ine mhando yepamusoro, inoshandiswa zvakanyanya muorganic synthesis, synthesis yemishonga yepakati uye Active Pharmaceutical Ingredient. (API) synthesis.Itiri pakati kazhinji mukugadzirwa kweArgatroban (CAS: 74863-84-6) kana Argatroban Monohydrate (CAS 141396-28-3).

Argatroban (CAS: 74863-84-6) is anticoagulant iyo idiki molecule yakananga thrombin inhibitor.Muna 2000, argatroban yakabvumirwa neFood and Drug Administration (FDA) yeprophylaxis kana kurapwa kwethrombosis kune varwere vane heparin-induced thrombocytopenia (HIT).Muna 2002, yakatenderwa kushandiswa panguva yepercutaneous coronary interventions kune varwere vane HIT kana vari panjodzi yekuigadzira.Muna 2012, yakatenderwa neMHRA kuUK kuti iite anticoagulation muvarwere vane heparin-induced thrombocytopenia Type II (HIT) vanoda parenteral antithrombotic therapy.

Nyora meseji yako pano ugotitumira